[go: up one dir, main page]

FI925547L - Nya vitamin d analoger - Google Patents

Nya vitamin d analoger Download PDF

Info

Publication number
FI925547L
FI925547L FI925547A FI925547A FI925547L FI 925547 L FI925547 L FI 925547L FI 925547 A FI925547 A FI 925547A FI 925547 A FI925547 A FI 925547A FI 925547 L FI925547 L FI 925547L
Authority
FI
Finland
Prior art keywords
analogues
new vitamin
vitamin
new
Prior art date
Application number
FI925547A
Other languages
English (en)
Other versions
FI103791B1 (fi
FI925547A0 (fi
FI103791B (fi
Inventor
Claus Aage Svensgaard Bretting
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI925547L publication Critical patent/FI925547L/fi
Publication of FI925547A0 publication Critical patent/FI925547A0/fi
Application granted granted Critical
Publication of FI103791B1 publication Critical patent/FI103791B1/fi
Publication of FI103791B publication Critical patent/FI103791B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI925547A 1990-08-15 1992-12-07 Menetelmä ja välituote uusien D-vitamiinianalogien valmistamiseksi FI103791B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909017890A GB9017890D0 (en) 1990-08-15 1990-08-15 Chemical compounds i
GB9017890 1990-08-15
DK9100200 1991-07-11
PCT/DK1991/000200 WO1992003414A1 (en) 1990-08-15 1991-07-11 Novel vitamin d analogues

Publications (4)

Publication Number Publication Date
FI925547L true FI925547L (fi) 1992-12-07
FI925547A0 FI925547A0 (fi) 1992-12-07
FI103791B1 FI103791B1 (fi) 1999-09-30
FI103791B FI103791B (fi) 1999-09-30

Family

ID=10680686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925547A FI103791B (fi) 1990-08-15 1992-12-07 Menetelmä ja välituote uusien D-vitamiinianalogien valmistamiseksi

Country Status (20)

Country Link
US (1) US5447924A (fi)
EP (1) EP0543864B1 (fi)
JP (1) JP3246914B2 (fi)
KR (1) KR100203227B1 (fi)
AT (1) ATE115562T1 (fi)
AU (1) AU636510B2 (fi)
CA (1) CA2078555C (fi)
CZ (1) CZ286485B6 (fi)
DE (1) DE69105981T2 (fi)
DK (1) DK0543864T3 (fi)
ES (1) ES2068601T3 (fi)
FI (1) FI103791B (fi)
GB (1) GB9017890D0 (fi)
GR (1) GR3014922T3 (fi)
IE (1) IE66241B1 (fi)
LT (1) LT3666B (fi)
LV (1) LV10089B (fi)
RU (1) RU2126384C1 (fi)
SK (1) SK281443B6 (fi)
WO (1) WO1992003414A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062520C (en) * 1991-03-11 1998-08-11 Hector F. Deluca Synthesis of 1-alpha-hydroxy-secosterol compounds
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
US5880114A (en) * 1993-06-16 1999-03-09 Wisconsin Alumni Research Foundation Treatment of immune deficiency with vitamin D compounds
US6291444B1 (en) 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
MA26481A1 (fr) * 1997-04-21 2004-12-20 Hoffmann La Roche Derives d'arylsecocholadiene
ES2206981T3 (es) * 1997-07-17 2004-05-16 F.Hoffmann-La Roche Ag Dihomo-seco-colestanos con dos enlaces insaturados en la cadena lateral.
CA2303248A1 (en) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
ES2368824T3 (es) 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
CN100334106C (zh) * 2001-10-19 2007-08-29 伊索泰克尼卡股份有限公司 环孢菌素类似物的合成
BR0315553A (pt) * 2002-10-23 2005-08-23 Leo Pharma As Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, método de tratamento ou profilaxia de hiperparatireoidismo secundário, e, uso de um composto, opcionalmente em conjunto com outro composto terapeuticamente ativo
AR041696A1 (es) 2002-10-23 2005-05-26 Leo Pharm Prod Ltd Compuestos analogos de vitamina d, composiciones que comprenden dichos compuestos analogos y su uso
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
ES2233209B1 (es) * 2003-11-28 2006-04-01 Laboratorios Viñas S.A. Compuestos monohalogenovinilderivados de vitamina d.
ES2234423B1 (es) * 2003-12-05 2006-03-01 Laboratorios Viñas, S.A. Procedimiento para la obtencion de derivados de vitamina d a partir de compuestos monohalogenovinilicos.
CN101217868A (zh) * 2005-05-10 2008-07-09 德米普瑟尔有限公司 用于皮肤护理的组合物和方法
ES2525410T3 (es) 2005-05-10 2014-12-22 Dermipsor Ltd Composiciones y métodos para el tratamiento de enfermedades hiperproliferativas dérmicas
MX2009002337A (es) * 2006-08-29 2009-03-20 Teva Pharma Composiciones farmacologicamente estables que incluyen compuestos que contienen vitamina d y corticosteroides con compatibilidad con bajo ph.
CA2981549A1 (en) 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
KR101880032B1 (ko) 2009-08-14 2018-07-20 베르그 엘엘씨 탈모증 치료용 비타민 d3 및 이의 유사체들
JP5738307B2 (ja) 2010-10-25 2015-06-24 帝人ファーマ株式会社 23−イン−ビタミンd3誘導体
CN105492081A (zh) 2013-05-29 2016-04-13 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
WO2017209934A1 (en) 2016-05-13 2017-12-07 Case Western Reserve University Autophagy activators for treating or preventing skin injury

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd 1α.25−ジヒドロキシ−26.27−ジメチルビタミンD↓3
JPS6172652A (ja) * 1984-09-14 1986-04-14 Asahi Glass Co Ltd 歯科材料用リン酸カルシウム系結晶性ガラス
CA1332841C (en) * 1984-11-27 1994-11-01 Noboru Kubodera Vitamin d derivatives and process for producing the same
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
JPS6253960A (ja) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd ビタミンd↓3の誘導体
JPH07100685B2 (ja) 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ/エス(レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ) 新規ビタミンd類似体
US4832875A (en) * 1985-11-21 1989-05-23 Taisho Pharmaceutical Co., Ltd. Vitamin D3 derivative
DE3865544D1 (de) * 1987-06-23 1991-11-21 Yamanouchi Pharma Co Ltd Vitamin d3-derivate.
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
AU614372B2 (en) 1988-04-21 1991-08-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
CA2010982C (en) 1989-02-28 2000-06-13 Toshio Matsumoto Osteogenesis promotion with use of vitamin d derivatives
US4948789A (en) 1989-03-28 1990-08-14 Chugai Seiyaku Kabushiki Kaisha Suppression of parathyroid hormone synthesis and secretion
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Also Published As

Publication number Publication date
LTIP965A (en) 1995-03-27
IE912462A1 (en) 1992-02-26
CZ286485B6 (en) 2000-04-12
GR3014922T3 (en) 1995-05-31
CA2078555C (en) 2002-11-26
DK0543864T3 (da) 1995-05-08
LV10089B (en) 1994-10-20
WO1992003414A1 (en) 1992-03-05
KR100203227B1 (ko) 1999-06-15
EP0543864B1 (en) 1994-12-14
SK281443B6 (sk) 2001-03-12
US5447924A (en) 1995-09-05
LV10089A (lv) 1994-05-10
FI103791B1 (fi) 1999-09-30
ATE115562T1 (de) 1994-12-15
AU8422391A (en) 1992-03-17
FI925547A0 (fi) 1992-12-07
SK372692A3 (en) 1995-04-12
GB9017890D0 (en) 1990-09-26
IE66241B1 (en) 1995-12-13
ES2068601T3 (es) 1995-04-16
CZ372692A3 (en) 1993-05-12
JPH06500089A (ja) 1994-01-06
DE69105981D1 (de) 1995-01-26
CA2078555A1 (en) 1992-02-16
EP0543864A1 (en) 1993-06-02
FI103791B (fi) 1999-09-30
AU636510B2 (en) 1993-04-29
JP3246914B2 (ja) 2002-01-15
LT3666B (en) 1996-01-25
DE69105981T2 (de) 1995-04-20
RU2126384C1 (ru) 1999-02-20

Similar Documents

Publication Publication Date Title
FI925547L (fi) Nya vitamin d analoger
FI934332L (fi) Nya proteaser
FI923515L (fi) Nya herbicider
FI925549L (fi) Nya azaheterocyklylmetyl-kromaner
FI923264L (fi) Nya herbicider
FI922746L (fi) Nya sulfonamider
FI930381L (fi) Nya vaermestabila pullulanaser
FI924453L (fi) Nya 9-amino-7-(substituerad)-6-demetyl-6-deoxitetracykliner
FI924557A0 (fi) Nya fenylpyrazolfungicider
FI934575A7 (fi) Nya centralt verkande substituerade fenylazacykloalkaner
FI950023L (fi) Uudet D-vitamiinianalogit
FI933252L (fi) Nya amylinagonistpeptider och anvaendning som amylinagonister
FI933451A0 (fi) Nya steroidestrar
FI924672A0 (fi) Nya antimikrobiella kinolontioureas
FI952972L (fi) Uudet D-vitamiinianalogit
FI933450A0 (fi) Nya steroider
FI933253L (fi) Nya amylinantagonistpeptider och anvaendning som amylinantagonister
FI943099A7 (fi) Uudet D-vitamiinianalogit
FI930199A7 (fi) Nya substituerade tiazolyl- och substituerade pyridinylderivat
FI951968A7 (fi) Uudet D-vitamiinianalogit
FI925086A0 (fi) Nya hybrid-vaextfaktorer
FI921614A7 (fi) Nya herbicider
FI951447L (fi) Uudet D-vitamiinianalogit
FI923050L (fi) Nya benzomorfaner och deras anvaendning som laekemedel
FI924934L (fi) Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning